Serum Progesterone >45 ng/mL at Embryo Transfer: Not Risky
A serum progesterone level greater than 45 ng/mL at the time of embryo transfer is not considered risky and does not require dose reduction or cycle cancellation. The most recent high-quality evidence demonstrates no ceiling effect for elevated progesterone levels on pregnancy outcomes.
Evidence Supporting Safety of High Progesterone Levels
The strongest and most recent evidence comes from a 2024 study specifically examining this question 1. This research evaluated progesterone levels up to and exceeding 40 ng/mL (90th percentile) in artificial frozen embryo transfer cycles and found:
- No need to reduce progesterone dose when levels exceed 40 ng/mL
- Progesterone levels between 20-40 ng/mL were associated with higher clinical pregnancy rates (p=0.043)
- The ceiling effect hypothesis was not supported—higher levels did not harm outcomes
This finding is corroborated by a large 2024 cohort study of 7,546 frozen embryo transfer cycles 2, which demonstrated:
- Women with P4 >40 ng/mL had similar live birth rates compared to lower levels
- No statistically significant impairment in pregnancy probability: adjusted OR = 0.77 (0.51-1.15), p=0.20
- Slightly higher but non-significant miscarriage rates: 18.0% vs 16.2%, p=0.6
Contradictory Evidence from Older Studies
Important caveat: One 2015 study 3 reported opposite findings, showing decreased live birth rates with P4 >20 ng/mL (65% vs 49%, p=0.02). However, this study:
- Is nearly a decade older than current evidence
- Used only intramuscular progesterone (not combined routes)
- Included only single euploid embryo transfers (highly selected population)
- Has been contradicted by multiple larger, more recent studies
Clinical Threshold Considerations
Recent 2025 evidence 4 suggests the lower threshold matters more than the upper limit:
- Optimal progesterone threshold: ≥26.95 ng/mL (sensitivity 82%, specificity 43%)
- Significantly lower clinical pregnancy rates when P4 ≤23.84 ng/mL
- Positive association between higher progesterone and live birth rates
A 2026 study 5 found that progesterone above 23.32 ng/mL was associated with lower pregnancy rates specifically in normal-weight POSEIDON Group 1 patients, but this effect was not seen in overweight/obese patients, suggesting BMI modifies the relationship.
Practical Recommendations
For progesterone levels >45 ng/mL at transfer:
- Proceed with embryo transfer as planned
- Do not reduce progesterone supplementation
- The primary concern should be ensuring adequate (not excessive) progesterone levels
- Focus on avoiding low progesterone (<20-25 ng/mL), which consistently shows worse outcomes across multiple studies 4, 6, 7
Common pitfall to avoid: Do not cancel cycles or reduce progesterone dosing based solely on high serum levels. The preponderance of recent evidence shows no harm from elevated progesterone, while low levels consistently correlate with poor outcomes.
The evidence quality is moderate overall, with most data from cohort studies rather than randomized trials, but the consistency of recent findings (2024-2026) showing safety of high progesterone levels outweighs the single contradictory 2015 study using a different protocol and population.